Toxicity and metabolism of the chloral-derived mammalian alkaloid 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in PC12 cells

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 61, Issue 7-8, 2006, Pages 601-610

  Bringmann, Gerhard ^a   Feineis, Doris ^a   Münchbach, Miriam ^a   God, Ralf ^a   Peters, Karl ^b   Peters, Eva Maria ^b   Mössner, Rainald ^a   Lesch, Klaus Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUT FÜR FESTKÖRPERFORSCHUNG   (Germany)

Author keywords

1 Trichloromethyl 1,2,3,4 tetrahydro carboline (TaClo); Cytotoxicity; Parkinson's Disease; Rat Phaeochromocytoma (PC12) Cells

Indexed keywords

MAMMALIA;

EID: 33748578965     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2006-7-822     Document Type: Article

References (28)

1. Akundi R. S., Macho A., Muñoz E., Lieb K., Bringmann G., Clement H. W., Hüll M., and Fiebich B. L. (2004), 1-Trichloromethyl-1,2,3,4- tetrahydro-β-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. J. Neurochem. 91, 263-273.
2. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., and Greenamyre T. (2000), Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neurosci. 3, 1301-1306.
3. Bringmann G. and Hille A. (1990), 1-Trichloromethyl-1,2,3,4-tetrahydro- β-carboline - a potential chloral-derived indol alkaloid in man. Arch. Pharm. 323, 567-569.
4. Bringmann G., Feineis D., Grote C., God R., Clement H. W., Sontag K. H., Janetzky B., Reichmann H., Rausch W. D., Riederer P., and Wesemann W. (1998), Highly halogenated tetrahydro-β-carbolines as a new class of dopaminergic neurotoxins. In: Pharmacology of Endogenous Neurotoxins - A Handbook (Moser A., ed.). Birkhäuser, Boston, Basel, Berlin, pp. 151-169.
5. Bringmann G., God R., Fähr S., Feineis D., Fornadi K., and Fornadi F. (1999), Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-β-carboline in human blood after intake of the hypnotic chloral hydrate. Anal. Biochem. 270, 167-175.
6. Bringmann G., Bruckner R., Munchbach M., Feineis D., God R., Wesemann W., Grote C., Herderich M., Diem S., Lesch K. P., Mössner R., and Storch A. (2000a), 'TaClo', a chloral-derived mammalian alkaloid with neurotoxic properties. In: Neurotoxic Factors in Parkinson's Disease and Related Disorders (Storch A. and Collins M. A., eds.). Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht, London, Moscow, pp. 145-149.
7. Bringmann G., Feineis D., Bruckner R., Blank M., Peters K., Peters E. M., Reichmann H., Janetzky B., Grote C., Clement H. W., and Wesemann W. (2000b), Bromal-derived tetrahydro-β-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration. Bioorg. Med. Chem. 8, 1467-1478.
8. Bringmann G., Münchbach M., Feineis D., Faulhaber K., and Ihmels H. (2001), Studies on single-strand scissions to cell-free plasmid DNA by the dopaminergic neurotoxin 'TaClo' (1-trichloromethyl-1,2,3,4-tetrahydro-β- carboline). Neurosci. Lett. 304, 41-44.
9. Bringmann G., Münchbach M., Feineis D., Messer K., Diem S., Herderich M., Clement H. W., Stichel-Gunkel C., and Kuhn W. (2002), "Chiral" and "achiral" determination of the neurotoxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline) from blood and urine samples by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. B 767, 321-332.
10. Bringmann G., Feineis D., Brückner R., God R., Grote C., and Wesemann W. (2006), Synthesis of radiolabelled 1-trichloromethyl-1,2,3,4- tetrahydro-β-carboline (TaClo), a neurotoxic chloral-derived mammalian alkaloid, and its biodistribution in rats. Eur. J. Pharm. Sci. 28, 412-422.
11. + as environmental neurotoxins. In: Neurotoxic Factors in Parkinson's Disease and Related Disorders (Storch A. and Collins M. A., eds.). Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht, London, Moscow, pp. 115-130.
12. Gerlach M., Xiao A. Y., Heim C., Lan J., God R., Feineis D., Bringman G., Riederer P., and Sontag K. H. (1998), 1-Trichloromethyl-1,2,3,4-tetrahydro- β-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats. Neurosci. Lett. 257, 17-20.
13. Gorell J. M., Rybicki B. A., Cole Johnson C., and Peterson E. L. (1999), Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 18, 303-308.
14. Gutsche B. and Herderich M. (1997) High-performance liquid chromatography-electrospray tandem mass spectrometry (HPLC-ESI-MS/MS) for the analysis of 1,2,3,4-tetrahydro-β-carboline derivatives. J. Chromatogr. A 767, 101-106.
15. Hartley A., Stone J. M., Heron C., Cooper J. M., and Schapira A. H. V. (1994), Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63, 1987-1990.
16. Janetzky B., Gille G., Abdel-mohsen M., God R., Rausch W. D., Bringmann G., and Reichmann H. (1999), Effects of highly halogenated β-carbolines on dopaminergic cells in culture and mitochondrial respiration. Drug Dev. Res. 46, 51-56.
17. Keller E. (1990), SCHAKAL 88. A FORTRAN Program for the Graphic Representation of Molecules and Crystallographic Models. Kristallographisches Institut der Universität Freiburg, Germany.
18. Kochen W., Kohlmüller D., De Biasi P, and Ramsay R. (2003), The endogenous formation of highly chlorinated tetrahydro-β-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Adv. Exp. Med. Biol. 527, 253-263.
19. Matsubara K., Gonda T., Sawada H., Uezono T., Kobayashi Y., Kawamura T., Ohtaki K. I., Kimura K., and Akaike A. (1998), Endogenously occurring β-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease. J. Neurochem. 70, 727-735.
20. McNaught K. St. P., Carrupt P. A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., and Marsden C. D. (1998), Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56, 921-933.
21. Naoi M., Maruyama W., Akao Y., and Yi H. (2002), Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. Neurotoxicol. Teratol. 24, 579-591.
22. Peters K., Peters E.-M., von Schnering H. G., Bringmann G., and God R. (1995), 2-Trifluoroacetyl-1-methyl-1,2,3,4-tetrahydro-β-carboline, a gaschromatographically useful derivative of the mammalian alkaloid eleagnine. Z. Naturforsch. 50b, 1564-1565.
23. Peura P. and Nousiainen E. (1981), Syntheses and spectral data of some 1-alkyl-substituted 1,2,3,4-tetrahydro-β-carbolines. Acta Pharm. Fenn. 90, 75-178.
24. Pezzoli G., Canesi M., Antonini A., Righini A., Perbellini L., Barichella M., Mariani C. B., Tenconi F., Tesei S., Zecchinelli A., and Leenders K. L. (2000), Hydrocarbon exposure and Parkinson's disease. Neurology 55, 667-673.
25. Przedborski S. and Vila M. (2001), MPTP: a review of its mechanisms of neurotoxicity. Clin. Neurosci. Res. 1, 407-418.
26. Riederer P., Foley P., Bringmann G., Feineis D., Brückner R., and Gerlach M. (2002), Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline: a biologically relevant neurotoxin? Eur. J. Pharmacol. 442, 1-16.
27. Sheldrick G. M. (1997), Program Package SHELXL-97, Release 4.1. Siemens Analytical X-Ray Instruments Inc., Madison, Wisconsin, USA.
28. Siemens (1996), P4 X-Ray Program System. Analytical X-Ray Instruments Inc., Madison, Wisconsin, USA.